Opinion

Video

Hepatic Artery Infusion Data in Unresectable Colorectal Cancer Liver Metastases

Author(s):

Ryan Merkow, MD, MSLouise Catherine Connell, MB BCh BAO, BMedSc

A surgical oncologist and gastrointestinal oncologist review data on hepatic artery infusion therapy in unresectable colorectal cancer liver metastases.

Related Videos
Suneel Kamath, MD
A panel of 3 experts on breast cancer
A panel of 3 experts on breast cancer
Jennifer R. Eads, MD, physician lead, GI Cancer Research, director, National Clinical Trials Network, Abramson Cancer Center, University of Pennsylvania, associate professor, clinical medicine (hematology-oncology), Penn Medicine, Perelman Center for Advanced Medicine
Olivia Aranha, MD, PhD
Michael Iglesia, MD, PhD
A panel of 3 experts on breast cancer
A panel of 3 experts on breast cancer
Related Content
Gastric cancer | Image Credit: © Rasi - stock.adobe.com
June 10th 2024

China’s NMPA Accepts BLA for Zanidatamab in HER2+ Biliary Tract Cancer

Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS
May 23rd 2024

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

Haibo Qiu, MD
June 4th 2024

Olverembatinib Demonstrates Early Activity, Tolerability in SDH-deficient GIST

Ryan Merkow, MD, MS, associate professor, surgery, director, Surgical Cancer Quality, associate director, Health Services Research, Department of Surgery, director, Hepatic Artery Infusion Pump Program, University of Chicago Medicine Comprehensive Cancer Center and Cancer Service Line; Louise Catherine Connell, MB BCh BAO, BMedSc, assistant attending physician, Memorial Sloan Kettering Cancer Center
May 2nd 2024

Merkow and Connell Highlight Considerations for HAI Pump Use in CRC

Shengfeng Li
June 3rd 2024

Bevacizumab Biosimilar Avzivi Receives Positive CHMP Opinion

Arndt Vogel, MD
June 2nd 2024

First-Line Camrelizumab Plus Rivoceranib Maintains Survival Benefit in Unresectable HCC